INDV
Indivior Pharmaceuticals Inc
1W: +5.9%
1M: -4.7%
3M: -16.1%
YTD: -14.7%
1Y: +218.8%
3Y: +77.4%
5Y: +254.4%
$30.47
-0.18 (-0.59%)
After Hours: $28.80 (-1.67, -5.48%)
Weekly Expected Move ±6.1%
$25
$27
$29
$31
$32
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Bullish
75
Insider+$0.2M
Congress—
ETF Holdings—
Key Statistics
Market Cap$3.8B
52W Range8.64-38
Volume1,808,808
Avg Volume2,534,118
Beta1.19
Dividend—
Analyst Ratings
Company Info
CEOJoseph J. Ciaffoni
Employees1,030
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2014-12-29
Websiteindivior.com
10710 Midlothian Turnpike
North Chesterfield, VA 23235
US
North Chesterfield, VA 23235
US
804 379 1090
About Indivior Pharmaceuticals Inc
Indivior Pharmaceuticals Inc is a holding company, which engages in the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence. Its products include Suboxone Film, Suboxone Tablet, and Subutex Tablet. It operates through the following geographical segments: United States, Rest of World, and United Kingdom. The company was founded on September 26, 2014 and is headquartered in North Chesterfield, VA.
Latest News
OCGN Completes Early Enrollment in Pivotal Stargardt Disease Study
5 Small Drug Stocks to Buy as Sector Recovery Gains Strength
Kodiak Q4 Loss Wider Than Expected, Pipeline Development in Focus
Kodiak Q4 Loss Wider Than Expected, Pipeline Development in Focus
AGIO Rises on Mitapivat Progress Toward Accelerated Approval in SCD
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Preblick Ryan | M-Exempt | 6,302 | — | 2026-03-14 |
| Preblick Ryan | F-InKind | 2,843 | $31.11 | 2026-03-14 |
| Preblick Ryan | M-Exempt | 6,302 | — | 2026-03-14 |
| Ryan Barbara | P-Purchase | 8 | $31.09 | 2026-03-13 |
| Ryan Barbara | P-Purchase | 31 | $32.56 | 2026-03-09 |